PT2670412T - Tratamento de edema da medula óssea com polissacáridos polissulfatados - Google Patents

Tratamento de edema da medula óssea com polissacáridos polissulfatados

Info

Publication number
PT2670412T
PT2670412T PT127415602T PT12741560T PT2670412T PT 2670412 T PT2670412 T PT 2670412T PT 127415602 T PT127415602 T PT 127415602T PT 12741560 T PT12741560 T PT 12741560T PT 2670412 T PT2670412 T PT 2670412T
Authority
PT
Portugal
Prior art keywords
oedema
treatment
bone marrow
marrow edema
polysulfated polysaccharides
Prior art date
Application number
PT127415602T
Other languages
English (en)
Portuguese (pt)
Inventor
Ghosh Peter
Original Assignee
Paradigm Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011900325A external-priority patent/AU2011900325A0/en
Application filed by Paradigm Biopharmaceuticals Ltd filed Critical Paradigm Biopharmaceuticals Ltd
Publication of PT2670412T publication Critical patent/PT2670412T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT127415602T 2011-02-02 2012-02-02 Tratamento de edema da medula óssea com polissacáridos polissulfatados PT2670412T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2011900325A AU2011900325A0 (en) 2011-02-02 Treatment of bone marrow edema (oedema) with polysulfated polysaccharides

Publications (1)

Publication Number Publication Date
PT2670412T true PT2670412T (pt) 2018-03-20

Family

ID=46602012

Family Applications (1)

Application Number Title Priority Date Filing Date
PT127415602T PT2670412T (pt) 2011-02-02 2012-02-02 Tratamento de edema da medula óssea com polissacáridos polissulfatados

Country Status (15)

Country Link
US (6) US9101650B2 (enExample)
EP (1) EP2670412B1 (enExample)
JP (1) JP5883458B2 (enExample)
KR (1) KR101840079B1 (enExample)
CN (1) CN103415293B (enExample)
AU (1) AU2012212398B2 (enExample)
CA (1) CA2826166C (enExample)
DK (1) DK2670412T3 (enExample)
ES (1) ES2664611T3 (enExample)
MY (1) MY164728A (enExample)
NO (1) NO2670412T3 (enExample)
PT (1) PT2670412T (enExample)
SG (1) SG192238A1 (enExample)
TW (1) TWI520740B (enExample)
WO (1) WO2012103588A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6444399B2 (ja) * 2013-10-22 2018-12-26 セル レセプター アーゲー 癌の処置に用いるための硫酸化多糖
CA3071585A1 (en) 2017-08-04 2019-02-07 Paradigm Biopharmaceuticals Ltd Treatment of bone marrow pathologies with polysulfated polysaccharides
CA3089077A1 (en) 2018-02-16 2019-08-22 Proteobioactives Pty Limited Methods and compositions for the treatment of pain and/or inflammation
CA3091632C (en) * 2018-02-28 2025-05-20 Paradigm Biopharmaceuticals Ltd TREATMENT OF POSTOPERATIVE JOINT PAIN WITH POLYSACCHARIDES POLYSULFATES
CN112888442A (zh) 2018-10-10 2021-06-01 帕拉迪生物制药有限公司 多硫酸化多糖治疗疼痛

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668116A (en) 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
US6593310B1 (en) * 2000-11-21 2003-07-15 Arthropharm Pty. Ltd. Treatment of osteoporosis
US6564083B2 (en) * 2000-12-18 2003-05-13 Hoffmann-La Roche Inc. Bone marrow edema as predictive of susceptibility to developing progressive osteoarthritis
DE10225551A1 (de) * 2002-06-06 2003-12-24 Schering Ag Verwendung von oral verfügbaren Prostacyclinderivaten für die Herstellung eines Arzneimittels zur Behandlung von Krankheiten, die mit Knochenmarködemen assoziiert sind
KR101828421B1 (ko) * 2007-12-04 2018-02-12 프로테오바이오엑티브스 피티와이 엘티디 전구 세포의 보호 및 그의 분화 조절

Also Published As

Publication number Publication date
US20220362284A1 (en) 2022-11-17
US9861657B2 (en) 2018-01-09
TW201309307A (zh) 2013-03-01
NO2670412T3 (enExample) 2018-06-02
US20140024614A1 (en) 2014-01-23
CA2826166C (en) 2017-05-09
CN103415293A (zh) 2013-11-27
US20240156858A1 (en) 2024-05-16
US9101650B2 (en) 2015-08-11
AU2012212398A1 (en) 2013-09-19
EP2670412B1 (en) 2018-01-03
EP2670412A4 (en) 2015-07-08
KR20140012655A (ko) 2014-02-03
US10610542B2 (en) 2020-04-07
KR101840079B1 (ko) 2018-03-19
CN103415293B (zh) 2016-08-10
DK2670412T3 (en) 2018-03-12
US20180021369A1 (en) 2018-01-25
MY164728A (en) 2018-01-30
AU2012212398B2 (en) 2014-06-05
US11406660B2 (en) 2022-08-09
JP5883458B2 (ja) 2016-03-15
WO2012103588A1 (en) 2012-08-09
US20210015849A1 (en) 2021-01-21
SG192238A1 (en) 2013-09-30
EP2670412A1 (en) 2013-12-11
JP2014504613A (ja) 2014-02-24
TWI520740B (zh) 2016-02-11
US20150297633A1 (en) 2015-10-22
ES2664611T3 (es) 2018-04-20
CA2826166A1 (en) 2012-08-09

Similar Documents

Publication Publication Date Title
EP2605827A4 (en) NON-INVASIVE TREATMENT OF BRONCHOCONSTRICTION
ZA201308417B (en) Tissue healing
PH12014500248A1 (en) Treatment of breast cancer
EP2773754A4 (en) Methods of Treatment
ZA201503714B (en) Production of high yields of bacterial polysaccharides
EP2675460A4 (en) TREATMENT OF FAT TISSUE UNDER CHIN
IL233111A0 (en) Preparations for the treatment of inflammation
ZA201307036B (en) Treatment of solid tumours
IL266368B (en) Treatment of diseases with nano-fibers of poly-n-acetyl glucosamine
IL228430A0 (en) Cancer treatment
BR112014016108A2 (pt) método de tratamento de perda óssea alvelar
IL232493A0 (en) A method for quantifying cancer treatment
PT2670412T (pt) Tratamento de edema da medula óssea com polissacáridos polissulfatados
PT2542591T (pt) Derivados silílicos de polissacáridos
ZA201308194B (en) Treatment of mastitis
ZA201402154B (en) Treatment of coal
SG10201605135YA (en) Application of treatment fluids to components
PT2547347T (pt) Processo para obtenção de própole não alergénica
GB2489071B (en) High-frequency module
EP2651041A4 (en) HIGH FREQUENCY MODULE
GB201121950D0 (en) Treatment process
GB201107467D0 (en) Novel treatment of pain
AU2011900325A0 (en) Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
EP2791324A4 (en) PROCESSING METHOD
GB201100455D0 (en) Methods relating to treatment